Hybrid immunity augments cross-variant protection against COVID-19 among immunocompromised individuals.

Autor: Quek AML; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Division of Neurology, Department of Medicine, National University Hospital, Singapore., Wang S; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Teng O; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Shunmuganathan B; Antibody Engineering Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Er BGC; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Division of Neurology, Department of Medicine, National University Hospital, Singapore., Mahmud NFB; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Division of Neurology, Department of Medicine, National University Hospital, Singapore., Ng IXQ; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Gupta R; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Tan ISL; Cambridge-NUS Cell Phenotyping Center, Center for Life Sciences, National University of Singapore, Singapore., Tan NY; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Qian X; Antibody Engineering Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Purushotorman K; Antibody Engineering Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Teoh HL; Division of Neurology, Department of Medicine, National University Hospital, Singapore., Ng KWP; Division of Neurology, Department of Medicine, National University Hospital, Singapore., Goh Y; Division of Neurology, Department of Medicine, National University Hospital, Singapore., Soon DTL; Division of Neurology, Department of Medicine, National University Hospital, Singapore., Tay SH; Division of Rheumatology, Department of Medicine, National University Hospital, Singapore., Teng GG; Division of Rheumatology, Department of Medicine, National University Hospital, Singapore., Ma M; Division of Rheumatology, Department of Medicine, National University Hospital, Singapore., Chandran NS; Division of Dermatology, Department of Medicine, National University Hospital, Singapore., Hartono JL; Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore., MacAry PA; Antibody Engineering Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Cambridge-NUS Cell Phenotyping Center, Center for Life Sciences, National University of Singapore, Singapore., Seet RCS; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Division of Neurology, Department of Medicine, National University Hospital, Singapore; Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Electronic address: raymond_seet@nus.edu.sg.

Publikováno v: The Journal of infection [J Infect] 2024 Oct; Vol. 89 (4), pp. 106238. Date of Electronic Publication: 2024 Aug 08.